Pilot Assessment of Lopinavir/Ritonavir and Maraviroc
| Status: | Completed |
|---|---|
| Conditions: | HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/11/2015 |
| Start Date: | December 2009 |
| End Date: | July 2011 |
| Contact: | Barry M. Rodwick, M. D. |
| Email: | Doc@DrRodwick.com |
| Phone: | 727-725-9931 |
Pilot Assessment of Lopinavir/Ritonavir and Maraviroc in Experienced Patients
This is a study to assess the response of lopinavir/ritonavir plus maraviroc (with no
nucleoside medications) in HIV patients failing their initial antiviral therapy.
nucleoside medications) in HIV patients failing their initial antiviral therapy.
As long-term toxicity to many of the nucleoside medications have become known, interest has
increased in treatment regimens that do not use these medications. This study is to assess
the response of one such "nucleoside-sparing" therapy in patients who are showing failure to
their initial nucleoside-containing treatment regimen.
increased in treatment regimens that do not use these medications. This study is to assess
the response of one such "nucleoside-sparing" therapy in patients who are showing failure to
their initial nucleoside-containing treatment regimen.
Inclusion Criteria:
- HIV viral load > 1,000 on current antiviral medications
- No resistance to study medications
- Over 18 years of age
Exclusion Criteria:
- Hepatitis B co-infection
- Pregnancy
- Previous therapy with either of the study medications
- Ongoing substance abuse
- Significant history of other physical disease
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials